Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products show growth. Here's what the company reported for the first quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: 75 cents adjusted vs. …